Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
posted on
Dec 02, 2019 10:08AM
But:
Biogen's Aducanumab targets the amyloid-beta plagues.
Not sure what Apabetalone targets to slow down cognitive impairment.
Koo